Article Versions Notes

Komatsu T, Watanabe K, Hamada N, Helmerhorst E, Oppenheim F, Lee MC-i. Association between Antimicrobial Peptide Histatin 5 Levels and Prevalence of Candida in Saliva of Patients with Down Syndrome. Antibiotics. 2021; 10(5):494. https://doi.org/10.3390/antibiotics10050494

Komatsu, Tomoko, Kiyoko Watanabe, Nobushiro Hamada, Eva Helmerhorst, Frank Oppenheim, and Masaichi Chang-il Lee. 2021. "Association between Antimicrobial Peptide Histatin 5 Levels and Prevalence of Candida in Saliva of Patients with Down Syndrome" Antibiotics 10, no. 5: 494. https://doi.org/10.3390/antibiotics10050494

Komatsu, T., Watanabe, K., Hamada, N., Helmerhorst, E., Oppenheim, F., & Lee, M. C.-i. (2021). Association between Antimicrobial Peptide Histatin 5 Levels and Prevalence of Candida in Saliva of Patients with Down Syndrome. Antibiotics, 10(5), 494. https://doi.org/10.3390/antibiotics10050494